"Prompt" for PREEMPT: Dotting the I's and Crossing the T's With Ultrasound.
J Ultrasound Med
; 2024 Jul 02.
Article
en En
| MEDLINE
| ID: mdl-38953410
ABSTRACT
The management of chronic migraine (CM) underwent a significant shift with the introduction of onabotulinumtoxin A (BoNT-A) injections following the landmark PREEMPT trial in 2010. Despite its efficacy, the existing injection protocol lacks precision, prompting a call for revision in light of modern ultrasound (US)-guided techniques. This article highlights the potential of US-guided injections to enhance accuracy, safety, and efficacy in CM treatment. By providing real-time visualization and addressing anatomical variations, US guidance offers a promising avenue for optimizing BoNT-A delivery, minimizing adverse effects, and ensuring therapeutic success.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
J Ultrasound Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
Turquía